Optimising cluster survey design for planning schistosomiasis preventive chemotherapy

26 May 2017
Knowles SCL, Sturrock HJW, Turner H, Whitton JM, Gower CM, Jemu S, Phillips AE, Meite A, Thomas B, Kollie K, Thomas C, Rebollo MP, Styles B, Clements M, Fenwick A, Harrison WE, Fleming FM
MDA; mass drug administration; schistosomes